Suppr超能文献

拉贝洛尔在动物和人体内的代谢。

Metabolism of labetalol by animals and man.

作者信息

Martin L E, Hopkins R, Bland R

出版信息

Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):695-710.

PMID:990152
Abstract

1 The disposition and metabolism of labetalol and either 14C- or 3H-labetalol has been studied in mouse, rat, rabbit, dog and man. 2 Radiolabelled labetalol was administered orally at doses of 100 mg/kg to the mouse, up to 50 mg/kg to the rat and rabbit, 20 mg/kg to the dog and 200 mg to man. From measurements of the total plasma radioactivity it was shown that labetalol was well absorbed by all the species. When the measurements of plasma radioactivity and labetalol concentrations were compared, it was found labetaol had been extensively metabolized by the first-pass effect in rat, rabbit and man. Metabolism by this route occurred to a lesser extent in the dog. 3 Radiochemical analysis of the tissues from rats, rabbits and dogs showed that the highest concentrations of radioactivity were found in the lung, liver and kidney. Very little radioactivity was present in the brain. Over 99% of the radioactivity was cleared from the tissues by 7 d. When doses of up to 200 mg 14C-labetalol/kg were given to pregnant rats and 50 mg 14C-labetalol/kg to pregnant rabbits, autoradiographic and radiochemical analysis of the full-term foetuses showed that only small amounts of radioactivity were present in the foetus. 4 The mouse excreted 72%, the rate 48%, the rabbit 61%, the dog 66% and man 60% of the oral dose of radioactivity in the urine. Analysis of themouse and rat faeces showed that the remainder of the dose of radioactivity was excreted in the faeces. 5 Radiochemical analysis of the urine and faeces collected from rats and dogs after an intravenous dose of 1 mg 14C- and 3H-labetalol/kg showed that excretion of radioactivity occurred via both the kidney and bile. 6 An intravenous dose of 1 mg 3H-labetalol/kg to dog and 1 mg 'cold' labetalol/kg to man was not as extensively metabolized as a similar oral dose. 7 The percentage of the dose excreted in the urine as unchanged drug was 2% in the rabbit, 11% in the rat, 19% in the dog and up to 5% in man. The O-phenyl glucuronide was the major metabolite present in the mouse, rat, and rabbit urine. Dog and man also formed this metabolite, but to a lesser extent. A second glucuronide was the major metabolite present in dog urine. This was probably formed through conjugation of glucuronic acid was the secondary alcohol group of labetalol. The major metabolite present in human urine was an unidentified conjugate of labetalol. Minor metabolites of labetalol present in rat, rabbit and dog urine were hydroxylabetalol and its glucuronyl conjugate.

摘要
  1. 已在小鼠、大鼠、兔子、狗和人体中研究了拉贝洛尔以及14C - 或3H - 拉贝洛尔的处置和代谢情况。2. 给小鼠口服放射性标记的拉贝洛尔,剂量为100mg/kg;给大鼠和兔子口服的剂量最高可达50mg/kg;给狗口服的剂量为20mg/kg;给人体口服的剂量为200mg。通过测量血浆总放射性表明,所有物种对拉贝洛尔的吸收都很好。当比较血浆放射性测量值和拉贝洛尔浓度时,发现拉贝洛尔在大鼠、兔子和人体中因首过效应而被广泛代谢。这种途径的代谢在狗中发生的程度较小。3. 对大鼠、兔子和狗的组织进行放射化学分析表明,在肺、肝和肾中发现的放射性浓度最高。脑中的放射性很少。超过99%的放射性在7天内从组织中清除。给怀孕大鼠给予高达200mg 14C - 拉贝洛尔/kg的剂量,给怀孕兔子给予50mg 14C - 拉贝洛尔/kg的剂量,对足月胎儿进行放射自显影和放射化学分析表明,胎儿中仅存在少量放射性。4. 小鼠经尿液排泄了口服剂量放射性的72%,大鼠为48%,兔子为61%,狗为66%,人体为60%。对小鼠和大鼠粪便的分析表明,放射性剂量的其余部分通过粪便排泄。5. 对静脉注射1mg 14C - 和3H - 拉贝洛尔/kg后从大鼠和狗收集的尿液和粪便进行放射化学分析表明,放射性通过肾脏和胆汁排泄。6. 给狗静脉注射1mg 3H - 拉贝洛尔/kg和给人体静脉注射1mg“非放射性”拉贝洛尔/kg时,其代谢程度不如类似口服剂量广泛。7. 以未变化药物形式经尿液排泄的剂量百分比在兔子中为2%,在大鼠中为11%,在狗中为19%,在人体中高达5%。O - 苯基葡萄糖醛酸苷是小鼠、大鼠和兔子尿液中存在的主要代谢物。狗和人体也形成这种代谢物,但程度较小。第二种葡萄糖醛酸苷是狗尿液中存在的主要代谢物。这可能是通过葡萄糖醛酸与拉贝洛尔的仲醇基团结合形成的。人体尿液中存在的主要代谢物是一种未鉴定的拉贝洛尔共轭物。大鼠、兔子和狗尿液中存在的拉贝洛尔次要代谢物是羟基拉贝洛尔及其葡萄糖醛酸共轭物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验